MARY BETH MENDOZA: Open Payments
NPI 1194786186 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 60 payments from 18 companies in 2025. Trend: 2023 $490 · 2024 $818 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 20 | $378 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $125 |
| Ferring Pharmaceuticals Inc. | 5 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| Janssen Pharmaceuticals, Inc | 4 | $98 |
| Janssen Biotech, Inc. | 5 | $92 |
| PFIZER INC. | 3 | $57 |
| 180 Medical, Inc. | 2 | $52 |
| Tempus AI, Inc | 2 | $50 |
| Dendreon Pharmaceuticals LLC | 2 | $48 |
Products named: GEMTESA, ERLEADA, Nubeqa, ADSTILADRIN, ORGOVYX, PLUVICTO, XTANDI, XT CDX.
Industry payments across MD — which companies pay providers there.
